WANBURY240.65

Wanbury Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹789 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2025
Revenue from Operations499.6575.6599.5629.8
Other Income0.93.03.54.7
Total Income500.6578.6603.0634.5
Expenses
+ Cost of Materials Consumed257.5289.2277.9286.5
+ Purchases of Stock-in-Trade16.017.315.114.9
+ Changes in Inventories29.1-3.91.52.2
+ Employee Benefit Expense81.086.9104.2107.8
+ Finance Costs21.429.237.036.9
+ Depreciation & Amortisation12.413.013.313.7
+ Other Expenses92.9116.1124.5130.5
Total Expenses510.3547.9573.5592.4
EBITDA23.270.076.388.0
EBIT10.857.063.074.4
Profit
PBT before Exceptional Items-9.730.829.642.1
+ Exceptional Items-0.625.60.00.0
Pretax Income-10.356.329.642.1
+ Current Tax0.00.05.95.9
+ Deferred Tax0.10.4-6.8-6.7
Tax Expense0.10.4-1.0-0.9
Net Income-10.456.030.543.0
+ Net Income — Continuing Ops-10.456.030.543.0
+ Other Comprehensive Income0.1-0.7-0.4-0.5
Total Comprehensive Income-10.355.230.242.5
Per Share
Basic EPS-6.1826.399.3213.50
Diluted EPS-6.1826.078.9812.97
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.4
+ Items NOT to be Reclassified to P&L0.1-1.1-0.5-0.5
+ Tax on Items NOT to be Reclassified-0.2
+ Tax on Items NOT to be Reclassified — alt tag0.0-0.4
+ Items to be Reclassified to P&L-0.0
+ Tax on Items to be Reclassified-0.0
+ Tax on Items to be Reclassified — alt tag-0.1-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-3.009.299.3213.12
Diluted EPS — Continuing Operations-3.009.188.9812.62
Basic EPS — Discontinued Operations-3.1817.100.000.38
Diluted EPS — Discontinued Operations-3.1816.890.000.35
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit197.1273.0305.0326.3
Gross Margin %39.4447.4350.8851.80
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-9.730.829.642.1
− Exceptional Items (reconciliation)-0.625.60.00.0
Net Income Adj (tax-effected)-9.830.630.543.0
EPS Adj-5.8314.429.3213.50
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital32.70.132.832.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.